| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Thomas Thum | Q42250812 |
| P2093 | author name string | Ariana Foinquinos | |
| Claudia Bang | |||
| Janika Viereck | |||
| P2860 | cites work | Detection of microRNA expression in human peripheral blood microvesicles | Q21144210 |
| PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor | Q22254096 | ||
| Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes | Q24312187 | ||
| Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions | Q24319987 | ||
| Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages | Q24337080 | ||
| Circulating microRNAs are new and sensitive biomarkers of myocardial infarction | Q24606701 | ||
| Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2 | Q24648959 | ||
| A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure | Q24673535 | ||
| Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair | Q26852506 | ||
| Cross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequences | Q27021613 | ||
| The functions of animal microRNAs | Q27860621 | ||
| Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice | Q28115423 | ||
| Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines | Q28242982 | ||
| Role of miR-21 in the pathogenesis of atrial fibrosis | Q28270271 | ||
| Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes. | Q47835430 | ||
| Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice | Q48021845 | ||
| Gene expression of natriuretic peptide receptors in myocardial cells | Q48070375 | ||
| B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation | Q48092800 | ||
| Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression | Q48350568 | ||
| Phenylephrine, endothelin, prostaglandin F2alpha' and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro | Q48361809 | ||
| Interaction of myocytes and nonmyocytes is necessary for mechanical stretch to induce ANP/BNP production in cardiocyte culture. | Q48465816 | ||
| Acute pressure overload could induce hypertrophic responses in the heart of angiotensin II type 1a knockout mice | Q48482767 | ||
| Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes | Q48587473 | ||
| Cardiac fibroblasts influence cardiomyocyte phenotype in vitro. | Q51083125 | ||
| Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy. | Q51564269 | ||
| Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21. | Q53398171 | ||
| Expression of immunological molecules by cardiomyocytes and inflammatory and interstitial cells in rat autoimmune myocarditis. | Q53666472 | ||
| MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway. | Q54300156 | ||
| ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy. | Q54322067 | ||
| Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. | Q54356342 | ||
| GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. | Q54623768 | ||
| Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans | Q37007126 | ||
| Atrial natriuretic peptide is negatively regulated by microRNA-425. | Q37052917 | ||
| Pathological ventricular remodeling: mechanisms: part 1 of 2 | Q37241166 | ||
| Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease | Q37261502 | ||
| Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro | Q37350080 | ||
| Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism | Q37385629 | ||
| IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. | Q37415365 | ||
| Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart | Q37794503 | ||
| Transforming growth factor (TGF)-β signaling in cardiac remodeling. | Q37808014 | ||
| MicroRNA involvement in immune activation during heart failure | Q37866669 | ||
| Small changes can make a big difference - microRNA regulation of cardiac hypertrophy | Q37942364 | ||
| Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1 | Q28294343 | ||
| miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling | Q28304542 | ||
| Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells | Q28482226 | ||
| Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse | Q28506680 | ||
| MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts | Q28511032 | ||
| Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c | Q28511141 | ||
| Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A | Q28511919 | ||
| MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension | Q28565620 | ||
| Mechanical stretch via transforming growth factor-β1 activates microRNA-208a to regulate hypertrophy in cultured rat cardiac myocytes | Q28567373 | ||
| Gene Expression, Secretion, and Autocrine Action of C-Type Natriuretic Peptide in Cultured Adult Rat Cardiac Fibroblasts | Q28575103 | ||
| Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38‐MAPK and ERK1/2 | Q28578104 | ||
| Production and autocrine/paracrine effects of endogenous insulin-like growth factor-1 in rat cardiac fibroblasts | Q28578687 | ||
| Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype | Q28581981 | ||
| IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system | Q28585033 | ||
| A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis | Q28591604 | ||
| Cardiotrophin-1 stimulation of cardiac fibroblast growth: roles for glycoprotein 130/leukemia inhibitory factor receptor and the endothelin type A receptor | Q28627059 | ||
| Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs | Q28941769 | ||
| SMAD proteins control DROSHA-mediated microRNA maturation | Q28941771 | ||
| Platelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts | Q29347051 | ||
| Treatment of HCV infection by targeting microRNA | Q29547712 | ||
| Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma | Q29547772 | ||
| Export of microRNAs and microRNA-protective protein by mammalian cells | Q29614234 | ||
| MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins | Q29615034 | ||
| MicroRNA-133 controls cardiac hypertrophy | Q29616572 | ||
| Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection | Q29618076 | ||
| Functional delivery of viral miRNAs via exosomes | Q29619574 | ||
| Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis | Q29619873 | ||
| Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression | Q30466550 | ||
| Cardiac fibroblast: the renaissance cell | Q30467800 | ||
| Inhibition of miR-29 by TGF-beta-Smad3 signaling through dual mechanisms promotes transdifferentiation of mouse myoblasts into myofibroblasts | Q31052506 | ||
| Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload | Q33559670 | ||
| MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts | Q33580704 | ||
| Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction | Q33642021 | ||
| The extracellular matrix: at the center of it all. | Q33665667 | ||
| Effects of interleukin-33 on cardiac fibroblast gene expression and activity | Q33765909 | ||
| Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy | Q33963098 | ||
| The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis | Q34112864 | ||
| Non-cardiomyocyte microRNAs in heart failure | Q37969738 | ||
| Horizontal transfer of microRNAs: molecular mechanisms and clinical applications | Q37982297 | ||
| A new level of complexity: the role of microRNAs in cardiovascular development. | Q37998442 | ||
| Arrhythmogenic implications of fibroblast-myocyte interactions | Q38003371 | ||
| Transcriptional regulation of the fetal cardiac gene program | Q38025586 | ||
| Cardiac myocyte-fibroblast interactions and the coronary vasculature | Q38044304 | ||
| Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends? | Q38046798 | ||
| Clinical applications for microRNAs in cancer | Q38065062 | ||
| Non-coding RNAs in cardiac remodeling and heart failure. | Q38132644 | ||
| Roadmap of miR-122-related clinical application from bench to bedside | Q38172567 | ||
| TNF alpha receptor expression in rat cardiac myocytes: TNF alpha inhibition of L-type Ca2+ current and Ca2+ transients | Q38288920 | ||
| IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation | Q38297511 | ||
| Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac Remodeling. | Q38509926 | ||
| The inhibitory effect of miRNA-1 on ET-1 gene expression | Q39351872 | ||
| TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. | Q39737677 | ||
| Platelet-derived growth factor involvement in myocardial remodeling following infarction | Q39903545 | ||
| Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model | Q40036183 | ||
| microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart | Q40036277 | ||
| Regulation of basic fibroblast growth factor (bFGF) and FGF receptors in the heart. | Q40528487 | ||
| Fibroblast and transforming growth factor expression in the cardiac myocyte | Q40786535 | ||
| Mechanisms of mechanical load-induced atrial natriuretic peptide secretion: role of endothelin, nitric oxide, and angiotensin II. | Q41681221 | ||
| Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts | Q41724668 | ||
| MicroRNA-24 regulates cardiac fibrosis after myocardial infarction | Q42089703 | ||
| Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature | Q42156210 | ||
| Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways | Q42456333 | ||
| CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis | Q42494057 | ||
| Searching for miR-acles in cardiac fibrosis | Q42560291 | ||
| Human cardiac stem cell differentiation is regulated by a mircrine mechanism | Q42705539 | ||
| Stretch-induced hypertrophy of isolated adult rabbit cardiomyocytes | Q42966852 | ||
| Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation | Q43065625 | ||
| Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner | Q43223343 | ||
| The time course of cardiac NF-kappaB activation and TNF-alpha secretion by cardiac myocytes after burn injury: contribution to burn-related cardiac contractile dysfunction | Q43960162 | ||
| Angiotensin II induced differentially expressed microRNAs in adult rat cardiac fibroblasts | Q44307084 | ||
| Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function | Q44319404 | ||
| Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta | Q44989718 | ||
| Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin | Q45146701 | ||
| Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure | Q45883186 | ||
| IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. | Q45968562 | ||
| Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts | Q46052970 | ||
| Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts | Q46061333 | ||
| IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis | Q46139327 | ||
| Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts. | Q46873529 | ||
| MicroRNA-24 regulates vascularity after myocardial infarction | Q47037318 | ||
| Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes | Q34189204 | ||
| Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture | Q34223350 | ||
| Inflammatory cytokines and postmyocardial infarction remodeling | Q34329136 | ||
| MicroRNA-27a regulates cardiomyocytic apoptosis during cardioplegia-induced cardiac arrest by targeting interleukin 10-related pathways | Q34473340 | ||
| MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophy | Q34551993 | ||
| Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts | Q34588914 | ||
| Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction | Q34603397 | ||
| Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading | Q34722251 | ||
| MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts. | Q34906347 | ||
| Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts | Q35042890 | ||
| Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism | Q35135394 | ||
| Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes | Q35216489 | ||
| The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology | Q35603401 | ||
| Cardiac hypertrophy is positively regulated by MicroRNA miR-23a. | Q35643799 | ||
| Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. | Q35685792 | ||
| Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy | Q35791763 | ||
| Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice | Q35796850 | ||
| MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? | Q35855552 | ||
| The dynamics of fibroblast-myocyte-capillary interactions in the heart | Q35869237 | ||
| Epigenetic modifications in cardiovascular disease. | Q35898458 | ||
| Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1. | Q35920106 | ||
| Nuclear accumulation of interferon gamma | Q35941912 | ||
| Role of MicroRNAs in Fibrosis | Q36093326 | ||
| Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function | Q36095572 | ||
| Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB | Q36174897 | ||
| Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts | Q36232642 | ||
| The role of natriuretic peptides in cardioprotection | Q36313449 | ||
| Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function | Q36378477 | ||
| Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury | Q36596636 | ||
| Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. | Q36734858 | ||
| Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways | Q36798027 | ||
| MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy | Q36802746 | ||
| The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. | Q36855897 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 290-301 | |
| P577 | publication date | 2014-02-21 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Regulatory RNAs and paracrine networks in the heart | |
| P478 | volume | 102 |
| Q43172104 | A snapshot of genetic and epigenetic basis of arrhythmia and heart failure |
| Q48099080 | Blunting of estrogen modulation of cardiac cellular chymase/RAS activity and function in SHR. |
| Q46326062 | Brain-Heart Interaction: Cardiac Complications After Stroke |
| Q26770294 | Cardiac Extracellular Vesicles in Normal and Infarcted Heart |
| Q61800745 | Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212 |
| Q38272573 | Epitranscriptional regulation of cardiovascular development and disease |
| Q28072307 | Facts and updates about cardiovascular non-coding RNAs in heart failure |
| Q38375945 | Good and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models |
| Q57005782 | Heterocellular signalling and crosstalk in the heart in ischaemia and heart failure |
| Q38591546 | Intercellular communication lessons in heart failure |
| Q35170871 | MicroRNA profiling of pericardial fluid samples from patients with heart failure |
| Q37641769 | MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat. |
| Q26770809 | Modulation of Hypercholesterolemia-Induced Oxidative/Nitrative Stress in the Heart |
| Q34356389 | Multi-omic integrated networks connect DNA methylation and miRNA with skeletal muscle plasticity to chronic exercise in Type 2 diabetic obesity |
| Q38344492 | Non-coding RNAs as direct and indirect modulators of epigenetic mechanism regulation of cardiac fibrosis |
| Q38247018 | Noncoding RNAs and myocardial fibrosis |
| Q46253112 | Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity. |
| Q53052642 | Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1. |
| Q91875264 | Role of CyPA in cardiac hypertrophy and remodeling |
| Q92408680 | Selective Heart Irradiation Induces Cardiac Overexpression of the Pro-hypertrophic miR-212 |
| Q99237852 | Use of an Exposome Approach to Understand the Effects of Exposures From the Natural, Built, and Social Environments on Cardio-Vascular Disease Onset, Progression, and Outcomes |
| Q52752598 | [Non-coding RNA : Innovative regulators with therapeutic perspective]. |
Search more.